Henshaw Capital’s Genmab GMAB Stock Holding History

Henshaw Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,204	Closed	-$227K	–	337
2021 Q3	$227K	Hold	5,204	–	–	0.01%	301
2021 Q2	$212K	Buy	+5,204	New	+$201K	0.01%	335
2021 Q1	–	Sell	-5,204	Closed	-$212K	–	361
2020 Q4	$212K	Buy	+5,204	New	+$195K	0.02%	326
2020 Q1	–	Sell	-9,509	Closed	-$212K	–	294
2019 Q4	$212K	Buy	+9,509	New	+$208K	0.02%	258

Other funds holding GMAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Henshaw Capital's GMAB Position: Q4 2021 in Review

Henshaw Capital sold out of Genmab (GMAB) in Q4 2021, closing a stake of 5,204 shares — an estimated $227K sold.

Henshaw Capital first reported a position in GMAB in Q4 2019 and held it in 4 quarters. The position peaked at $227K in Q3 2021. 211 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

Henshaw Capital reported no remaining Genmab position as of Q4 2021 after selling out during the quarter.
Henshaw Capital sold 5,204 Genmab shares in Q4 2021, an estimated $227K.
Henshaw Capital first reported a position in Genmab in Q4 2019 and held it in 4 quarters.
Henshaw Capital's Genmab position peaked at $227K in Q3 2021.
211 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on Henshaw Capital's 13F filing for Q4 2021, filed 28 May 2026.